Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 Biomarker group BEFREE In the past few years, the Paraoxonase multigene family (<i>PON1, PON2, PON3</i>) has been shown to play an important role in pathogenesis of cardiovascular disorders including coronary artery disease (CAD). 31816846 2019
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 Biomarker group BEFREE Supporting a direct role for PON2 in cardiovascular diseases, <i>Pon2</i> deficiency in mice promotes atherogenesis through incompletely understood mechanisms. 29439952 2018
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 AlteredExpression group BEFREE The higher levels of PON2 in females may explain the lower frequency of neurological and cardiovascular diseases in females and the ability to identify males but not females with Parkinson's disease using a special PON1 status assay. 27238723 2016
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 GeneticVariation group BEFREE Large-scale epidemiologic studies are needed to further examine the relationship between PON2 genetic polymorphisms and risk for CVD. 19474728 2009
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 Biomarker group CTD_human Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality. 19152805 2009
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 Biomarker group BEFREE Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases. 19082953 2008
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 GeneticVariation group BEFREE (1,2) The PON1 activity and the polymorphism of the PON1 and PON2 genes have been found to be associated with risk of cardiovascular diseases such as hypercholesterolaemia, non-insulin-dependent diabetes, coronary heart disease (CHD) and myocardial infaction. 11803456 2002
Entrez Id: 5445
Gene Symbol: PON2
PON2
0.370 GeneticVariation group BEFREE In our study we assessed the frequency and genotype distribution of the PON1 and PON2 polymorphisms in 197 patients with familial hypercholesterolemia (FH), to determine the possible association between these mutations and susceptibility for CVD. 11257265 2001